Hepatitis C virus infection, increased serum ferritin and hyperinsulinemia. 2001

A Garrido Serrano, and F J Guerrero Igea, and J A Lepe Jiménez, and S Palomo Gil, and A Grilo Reina
Department of Gastrointestinal Medicine, Hospital Comarcal de Riotinto, Huelva, Spain.

OBJECTIVE Recent studies have reported a high prevalence of diabetes mellitus in populations infected with Virus C (HCV). The aim of this study is two-fold: a) to support the hypothesis of hyperinsulinemia as a risk factor for developing diabetes in these patients, with a prospective determination of baseline insulinemia in non-diabetic cirrhotic patients infected with HCV, comparing their values with those of a group of non-HCV non-diabetic cirrhotic patients; b) to investigate in both groups the factors associated to increased peripheral resistance to insulin. METHODS Thirty two HCV cirrhotic diabetic patients (group I) and 41 non-diabetic cirrhotic patients of other etiologies (group II) participated in the study. Baseline insulinemia, as well as factors related to insulin resistance such as age, anthropometric indexes, stage of cirrhosis development using the Child-Pugh index, serum ferritin and treatment with insulin resistance inducing drugs were compared in both groups. RESULTS Average baseline insulinemia in group I was 21.5 mU/ml (18.6-24.4), vs 14 mU/ml (10-18) in group II (p < 0.001), and the percentage of hyperinsulinemia was 87.5% (72.5-95.9) vs 56.1% (40.8-70.6), respectively (p < 0.01). No differences were observed between the two groups when comparing the following variables: age [54.4 (48.3-60.6) vs 59.9 (56.3-62.7) years of age, NS], weight [72.9 (69.5-76.3) vs 74.2 (70.8-77.7) kg, NS], height [163.6 (160.5-166.7) vs 161.3 (159.4-163.2)] cm, NS], body mass index [27.6 (26.1-29.1) vs 28.4 (27.3-29.5) kg/m2 of height, NS]; and Child-Pugh staging score (A: 31 vs 27; B: 0 vs 7; C: 1 vs 7, NS). However, serum ferritin levels in group I patients were higher than those in Group II [123.3 (12.4-289.3) vs 65.5 (2.4-306) ng/ml, p < 0.05]. It must be considered that at the recruitment 3 patients in Group I were taking either diuretics or non-selective beta-adrenergic blockers, compared to 14 patients in Group II, p < 0.01. Finally, the multivariate logistic regression analysis showed that insulinemia values (OR = 1.21; CI 95% 1.09-1.34, p < 0.001) and ferritin levels (OR = 1.21; CI 95% 1.02-2.69, p < 0.04) were independent variables associated to HCV infection. CONCLUSIONS HCV-positive non-diabetic cirrhotic patients have higher baseline insulinemia levels and increased prevalence of hyperinsulinemia than cirrhosis due to other etiologies. This could be explained by an increase of peripheral insulin resistance, mediated by the increase of iron deposits in these patients, and could be responsible for the increased risk of developing diabetes mellitus.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005293 Ferritins Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. Basic Isoferritin,Ferritin,Isoferritin,Isoferritin, Basic
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006946 Hyperinsulinism A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. Compensatory Hyperinsulinemia,Endogenous Hyperinsulinism,Exogenous Hyperinsulinism,Hyperinsulinemia,Hyperinsulinemia, Compensatory,Hyperinsulinism, Endogenous,Hyperinsulinism, Exogenous

Related Publications

A Garrido Serrano, and F J Guerrero Igea, and J A Lepe Jiménez, and S Palomo Gil, and A Grilo Reina
June 1995, Hepatology (Baltimore, Md.),
A Garrido Serrano, and F J Guerrero Igea, and J A Lepe Jiménez, and S Palomo Gil, and A Grilo Reina
September 2013, Journal of medical virology,
A Garrido Serrano, and F J Guerrero Igea, and J A Lepe Jiménez, and S Palomo Gil, and A Grilo Reina
January 2001, Medicina clinica,
A Garrido Serrano, and F J Guerrero Igea, and J A Lepe Jiménez, and S Palomo Gil, and A Grilo Reina
April 2014, Biochemical and biophysical research communications,
A Garrido Serrano, and F J Guerrero Igea, and J A Lepe Jiménez, and S Palomo Gil, and A Grilo Reina
February 1995, Medicina clinica,
A Garrido Serrano, and F J Guerrero Igea, and J A Lepe Jiménez, and S Palomo Gil, and A Grilo Reina
July 2011, Journal of medical virology,
A Garrido Serrano, and F J Guerrero Igea, and J A Lepe Jiménez, and S Palomo Gil, and A Grilo Reina
May 2020, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS),
A Garrido Serrano, and F J Guerrero Igea, and J A Lepe Jiménez, and S Palomo Gil, and A Grilo Reina
August 2003, Liver international : official journal of the International Association for the Study of the Liver,
A Garrido Serrano, and F J Guerrero Igea, and J A Lepe Jiménez, and S Palomo Gil, and A Grilo Reina
May 1999, Journal of hepatology,
A Garrido Serrano, and F J Guerrero Igea, and J A Lepe Jiménez, and S Palomo Gil, and A Grilo Reina
January 1994, Advances in experimental medicine and biology,
Copied contents to your clipboard!